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‘Compliance’	versus	‘adherence’	in	sport	injury	prevention:	Why	definition	matters		For	 sport	 injury	 prevention	 efforts	 to	 be	 successful,	 athletes	 must	 adopt,	 and	continue	 to	 use,	 preventive	 measures.[1]	 To	 this	 end,	 researchers	 have	conceptualized	 intervention	uptake	as	both	a	modifying	 factor	 in	efficacy	 trials,[2]	and	as	 an	outcome	 in	 effectiveness	 and	 implementation	 studies.[3]	While	 this	has	advanced	 our	 understanding	 of	 effective	 intervention	 design,	 dose-response	relationships,	 and	 barriers	 to	 program	 use,	 the	 definition	 of	 “uptake”	 has	 been	inconsistent.	Researchers	often	use	“compliance”	and	“adherence”	interchangeably,	overlooking	 important	differences	 in	these	constructs.[4]	We	propose	that	efficacy	trials	 require	 “compliance”,	 but	 effectiveness	 studies	 do	 not;	 instead,	 they	 should	measure	 and	 interpret	 “adherence”	 in	 real-life	 contexts.	 This	 distinction	 is	 an	important	 first	 step	 for	 developing	 a	 framework	 to	 guide	 appropriate	 selection	of	outcome	measures,	 measurement	 tools	 and	 analysis	 strategies	 to	 answer	 specific	research	questions.	“Compliance”	 refers	 to	 the	 act	 of	 an	 individual	 conforming	 to	 professional	recommendations	 with	 regard	 to	 prescribed	 dosage,	 timing	 and	 frequency	 of	 an	intervention.[6]	 This	 requires	 the	 measurement	 of	 behaviour	 relative	 to	 a	 fixed	standard,	 and	 results	 must	 be	 interpreted	 with	 reference	 to	 deviations	 from	 this	standard.	This	definition,	however,	implicitly	assumes	that	study	participants	must	“do	as	they	are	told”.[4-7]	Researchers	must	therefore	design	interventions	to	fit	the	user’s	context	(without	allowing	users	to	adapt	it	if	researchers	get	it	wrong),	or	at	least	understand	the	context	well	enough	to	interpret	findings	when	compliance	is	
		
below	 target.	 “Compliance”	 thereby	 addresses	 whether	 intervention	 components	were	 performed	 as	 directed,	 but	 does	 not	 contribute	 to	 our	 understanding	 of	 the	congruence	between	the	prescription	and	the	desired	outcome,	nor	how	behaviour	change	can	be	facilitated.	[6]			“Adherence”	is	a	process	influenced	by	the	environment,[5]	recognizing	that	behaviour	is	shaped	by	social	contexts	as	well	as	personal	knowledge,	motivations,	skills	 and	 resources.[4,5]	 This	 definition	 acknowledges	 that	 the	 recommended	intervention	 represents	one	of	many	possible	actions,	 and	 the	degree	 to	which	an	individual	chooses	to	pursue	the	suggested	behaviour	can	be	dynamic	and	situation-specific.	Therefore,	instead	of	framing	results	against	a	standard	of	“perfect	uptake”	(e.g.	 a	 difference	 score	 with	 maximum	 value	 of	 100%),	 it	 is	 understood	 that	individuals	 may	 use	 an	 intervention	 less	 than	 is	 recommended,	 more	 than	 is	recommended,	 or	 any	 amount	 in	 between	 (e.g.	 a	 range	 with	 no	 upper	 limit).	Interpretation	of	 research	 findings	must	account	 for	 individual	characteristics	and	other	factors	in	the	environment	to	explain	within-	or	between-subject	variability	in	behaviour,	beyond		simple	comparison	to	a	referent	standard.	Using	an	“adherence”	approach	 thereby	 speaks	 to	 real-world	 intervention	 use,	 but	 does	 not	 allow	 for	cause-effect	 relationships	 to	 be	 established	 between	 the	 intervention	 and	 injury	outcomes.	To	 illustrate	 the	 significance	of	 this	 issue	 in	 the	broader	medical	 literature,	Vrijens	 and	 colleagues	 systematically	 reviewed	 the	 terminology	 used	 to	 quantify	medication-taking	behaviours.[5]	In	146	studies	they	found	more	than	10	different	words	used	to	describe	the	outcome,	with	apparent	trends	in	their	use	over	time.[5]	
		
Specifically,	 “compliance”	was	most	 commonly	 used	 until	 roughly	 2002,	 at	 which	point	“adherence”	became	the	preferred	descriptor	alongside	a	paradigm	shift	in	the	medical	 community	 that	 viewed	 the	 patient-physician	 relationship	 as	 one	 of	cooperation	 rather	 than	 one	 of	 patient	 obedience.[5]	 The	 authors	 noted	 that	heterogeneity	 in	 terminology	 resulted	 in	 an	 inability	 to	 directly	 compare	 findings	between	 studies	 and	 challenges	 in	 applying	 evidence	 to	 practice	 due	 to	inconsistencies	 in	 the	outcome	measures	assumed	to	account	 for	 the	behaviour	 in	question.		Although	 the	 measurement	 of	 “uptake”	 is	 an	 evolving	 methodology,	vocabulary	 choice	 and	 operationalization	 in	 research	 should	 relate	 to	 the	 type	 of	study	being	undertaken.	In	efficacy	trials,	under	controlled	conditions	with	specific	intervention	 prescriptions	 to	 compare	 against	 actual	 behaviour,	 “compliance”	 is	appropriate.	 In	 practice,	 however,	 coaches	 and	 athletes	 have	 competing	 interests	related	 to	 performance,	 health,	 team	 dynamics,	 sport	 culture,	 and	 a	 host	 of	 other	contextual	 factors.	 In	this	sense,	personal	or	 institutional	values	and	priorities	will	influence	 intervention	 uptake	 regardless	 of	 the	 research	 aims.	 Therefore,	“adherence”	 should	 be	 the	 preferred	 construct	 in	 pragmatic	 trials,	 effectiveness	studies	and	when	considering	implementation	outside	of	research	applications.	[8]	Given	 the	 heterogeneity	 of	 implementation	 contexts	 for	 injury	 prevention	programs[1]	 the	generalizability	of	studies	 is	difficult	at	best.	The	use	of	disparate	intervention	 uptake	 definitions	 only	 compounds	 this	 problem	 by	 introducing	inconsistent	 operationalized	 measures	 with	 different	 interpretations	 [e.g.,	proportion	of	sessions	completed	per	protocol	(compliance)	versus	total	number	of	
		
exercises	completed	 in	a	season	(adherence)].	Consistency	 in	 language	and	proper	interpretation	 with	 respect	 to	 the	 construct	 under	 investigation	 is	 therefore	essential	to	the	conceptualization	of	outcomes	and	the	ability	to	translate	research	findings	 into	meaningful	 practice.	Measuring	 and	 valuing	 “compliance”	 in	 efficacy	trials	and	“adherence”	 in	effectiveness	studies	 is	a	 first	 step	 in	reconciling	current	methods	 and	 reporting	 standards	 in	 injury	 prevention	 with	 the	 broader	 medical	literature.	 It	also	pushes	 the	 field	beyond	simply	observing	 intervention	uptake	 to	exploring	 the	meaning	of	 uptake	 in	 the	broader	 context	 of	 injury	 outcomes,	 sport	performance,	and	athlete	health	and	wellbeing.		
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